• Snowflake recently presented at the HIMSS 2026 Global Health Conference and the 3rd Billington State and Local CyberSecurity Summit, underscoring its push into healthcare and public-sector data and security use cases.
• These appearances come as Snowflake highlights over 430 new AI features and deep partnerships with Anthropic, Google Cloud, and OpenAI, reflecting a broadening role in enterprise AI workloads.
• Now we’ll examine how Snowflake’s rapid rollout of hundreds of new AI capabilities could influence its existing investment narrative.

Find 49 companies with promising cash flow potential yet trading below their fair value.

Snowflake Investment Narrative Recap

To own Snowflake, you have to believe its AI‑native data platform can justify a premium valuation despite ongoing losses and heavy competition from cloud giants and AI‑first rivals. The near term catalyst remains whether its 430+ new AI features translate into higher, sustained consumption, while the biggest current risk is that legal and regulatory scrutiny, including active class actions, distracts management or raises questions about past disclosures. The latest healthcare and cybersecurity conferences do not materially change those drivers.

The most directly relevant update here is Snowflake’s expanded partnership with OpenAI, which makes advanced models natively available in Cortex AI. For investors, that sits at the heart of the AI workload catalyst: if enterprises standardize more of their AI development on Snowflake, it could support higher usage and stickier deployments, especially in regulated sectors like healthcare and the public sector that featured in its recent conference appearances.

Yet beneath the AI story, investors should be aware that ongoing securities class actions could still reshape how you think about Snowflake’s risk...

Snowflake's narrative projects $7.8 billion revenue and $497.5 million earnings by 2028. This requires 23.8% yearly revenue growth and an earnings increase of about $1.9 billion from -$1.4 billion today.

Uncover how Snowflake's forecasts yield a $282.90 fair value, a 62% upside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts were already assuming about US$7.3 billion revenue by 2028 with no profits, which is far more cautious than the AI‑driven adoption story and could look very different once these new healthcare and cybersecurity developments are fully reflected.

Explore 13 other fair value estimates on Snowflake - why the stock might be worth 35% less than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Snowflake research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Snowflake research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Snowflake's overall financial health at a glance.

Curious About Other Options?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Outshine the giants: these 22 early-stage AI stocks could fund your retirement.
• AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.